MedPath

Fluconazole

Fluconazole for Oral Suspension Rx only

Approved
Approval ID

13804efd-7cb3-431f-a6a7-bd6d1da5889e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 24, 2024

Manufacturers
FDA

Slate Run Pharmaceuticals

DUNS: 039452765

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluconazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70436-227
Application NumberANDA215738
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fluconazole
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 24, 2024
FDA Product Classification

INGREDIENTS (8)

SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95K
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
FLUCONAZOLEActive
Quantity: 40 mg in 1 mL
Code: 8VZV102JFY
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.